578 related articles for article (PubMed ID: 19201002)
21. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
Caramanos Z; DiMaio S; Narayanan S; Lapierre Y; Arnold DL
J Neurol Sci; 2009 Jul; 282(1-2):72-9. PubMed ID: 19232641
[TBL] [Abstract][Full Text] [Related]
22. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis.
Mesaros S; Rovaris M; Pagani E; Pulizzi A; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Martinelli V; Comi G; Filippi M
Arch Neurol; 2008 Sep; 65(9):1223-30. PubMed ID: 18779427
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
[TBL] [Abstract][Full Text] [Related]
24. Is progressive multiple sclerosis a gray matter disease?
Geurts JJ
Ann Neurol; 2008 Sep; 64(3):230-2. PubMed ID: 18825672
[No Abstract] [Full Text] [Related]
25. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
26. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.
Keegan BM; Giannini C; Parisi JE; Lucchinetti CF; Boeve BF; Josephs KA
Neurology; 2008 Mar; 70(13 Pt 2):1128-33. PubMed ID: 18287567
[TBL] [Abstract][Full Text] [Related]
27. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
28. Fractal dimension analysis of grey matter in multiple sclerosis.
Esteban FJ; Sepulcre J; de Miras JR; Navas J; de Mendizábal NV; Goñi J; Quesada JM; Bejarano B; Villoslada P
J Neurol Sci; 2009 Jul; 282(1-2):67-71. PubMed ID: 19167728
[TBL] [Abstract][Full Text] [Related]
29. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance evidence of cortical onset of multiple sclerosis.
Calabrese M; Gallo P
Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
[TBL] [Abstract][Full Text] [Related]
31. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
[TBL] [Abstract][Full Text] [Related]
32. The histopathology of grey matter demyelination in multiple sclerosis.
Bø L
Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
[TBL] [Abstract][Full Text] [Related]
33. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
Valsasina P; Benedetti B; Rovaris M; Sormani MP; Comi G; Filippi M
Neurology; 2005 Oct; 65(7):1126-8. PubMed ID: 16217074
[TBL] [Abstract][Full Text] [Related]
34. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
[TBL] [Abstract][Full Text] [Related]
35. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
Bagnato F; Ohayon JM; Ehrmantraut M; Chiu AW; Riva M; Ikonomidou VN
Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658
[TBL] [Abstract][Full Text] [Related]
36. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
Charil A; Dagher A; Lerch JP; Zijdenbos AP; Worsley KJ; Evans AC
Neuroimage; 2007 Jan; 34(2):509-17. PubMed ID: 17112743
[TBL] [Abstract][Full Text] [Related]
37. White matter volume is decreased in the brain of patients with neuromyelitis optica.
Chanson JB; Lamy J; Rousseau F; Blanc F; Collongues N; Fleury M; Armspach JP; Kremer S; de Seze J
Eur J Neurol; 2013 Feb; 20(2):361-7. PubMed ID: 22978568
[TBL] [Abstract][Full Text] [Related]
38. Novel image processing techniques to better understand white matter disruption in multiple sclerosis.
Goldberg-Zimring D; Warfield SK
Autoimmun Rev; 2006 Oct; 5(8):544-8. PubMed ID: 17027890
[TBL] [Abstract][Full Text] [Related]
39. Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
Karmon Y; Morrow SA; Weinstock A; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2012 Sep; 320(1-2):136-40. PubMed ID: 22698481
[TBL] [Abstract][Full Text] [Related]
40. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
